Intercity Announces Key Leadership Changes to Drive Growth and Innovation

By Anushka Malhotra

1 minute 11 seconds

Growth

Share:

Quick Read: Intercity announces strategic leadership changes with Andrew Jackson appointed as Group CEO and Charlie Blakemore as CEO of Intercity, signaling a commitment to sustained growth and innovation in the technology solutions sector.

Intercity, a leading technology solutions provider, is undergoing a transformative shift in its executive leadership, signalling a strategic move towards continued growth and innovation.

Photo: Charlie Blakemore, Intercity CEO and Andrew Jackson, Group CEO, Photo Credits: Intercity Technology

Andrew Jackson, the visionary CEO of Intercity for over 14 years, has been appointed as the Group CEO, reflecting his outstanding leadership in steering the company through significant diversification. Under his guidance, Intercity expanded its technology portfolio, embracing Communications, Cloud, Cyber Security, and Managed IT Services. Andrew will now spearhead the wider group's future, leveraging his expertise as a majority shareholder to drive integration, innovation, and strategic growth across an expanding portfolio.

Intercity's remarkable financial results, combined with exceptional customer service and prestigious awards, have solidified its position as an industry leader. Notable projects, recent acquisitions, and a commitment to eco-friendly initiatives highlight the company's growth trajectory.

In tandem with this transition, Charlie Blakemore, the Group Managing Director, will assume the role of CEO of Intercity. With a proven track record as Chief Operating Officer and Non-Executive Director, Charlie's leadership has been integral to the company's success. His appointment ensures a seamless transition, emphasizing continuity in the strategic direction and a commitment to sustained excellence.

Charlie's elevation to CEO marks a new era for Intercity, and his wealth of experience positions him to lead the company to greater achievements. Andrew Jackson expressed confidence in the future, stating, "With Charlie's invaluable experience and visionary leadership at Intercity, we are exceptionally well-positioned to achieve unprecedented success."

This leadership restructuring aligns with Intercity's dedication to diversification and strategic expansion, setting the stage for continued success in the dynamic technology landscape.

Read Press Release here.

What's new

West Midlands Health Tech Innovation Accelerator Unlocks Nearly £50M in Private Investment

The West Midlands Health Tech Innovation Accelerator (WMHTIA), led by the University of Birmingham, has generated an impressive £49.4 million in private co-investment within its first two years, significantly surpassing its original £14.5 million public funding allocation.

Funded through the Innovation Accelerator programme, coordinated by Innovate UK, the Department for Science, Innovation and Technology, and UK Research and Innovation, WMHTIA has become a leading force in advancing health technology innovation across the region.

The majority of the private investment—£36.3 million—was directly committed by investors to enterprises supported by the Accelerator. This achievement represents a threefold return on the initial public investment, demonstrating the strong investor confidence in the region’s health tech sector.

Powering Health Innovation Through Collaboration

The WMHTIA brings together 21 partners from academia, industry, and the NHS to help healthtech companies develop, validate, and commercialise cutting-edge medical technologies. So far, companies supported through the programme have also secured an additional £10 million in national public grants from agencies including NIHR, Eureka, and Innovate UK.

Including both public and private contributions, the total investment leveraged by WMHTIA now stands at £67.3 million.

Professor Adam Tickell, Vice-Chancellor, University of Birmingham:

We’re proud to support startups through the riskiest stages of innovation so more life-saving technologies reach patients. This exceptional investment proves what’s possible when academia, the NHS, and industry work together to drive economic growth and better health outcomes.

In March 2025, the Innovation Accelerator programme was extended with a further £30 million, including £4 million for the WMHTIA to continue supporting the region’s innovators in 2025/26.

Backing the Future of Health Tech

Richard Parker, Mayor of the West Midlands:

The West Midlands is leading medical tech innovation—from faster diagnoses to shorter hospital stays. Healthtech isn’t just improving lives; it’s creating secure, high-value jobs that drive inclusive growth.

Dean Cook, Executive Director of Place and Global, Innovate UK:

This programme shows how place-based innovation can unlock greater business investment in R&D. By connecting the region’s strengths, we’re creating high-value jobs and building globally significant innovation capability.

The WMHTIA continues to strengthen the region’s reputation as a national hub for health technology, with far-reaching benefits for patient care, job creation, and regional economic development.

By Anushka Malhotra

24 Jun